BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 30661920)

  • 1. Is the AJCC TNM staging system still appropriate for gastric cancer patients survival after 5 years?
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Huang CM; Li P
    Eur J Surg Oncol; 2019 Jun; 45(6):1115-1120. PubMed ID: 30661920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel TNM staging system for gastric cancer based on the metro-ticket paradigm: a comparative study with the AJCC-TNM staging system.
    Lu J; Zheng ZF; Wang W; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zhou ZW; Huang CM; Zheng CH; Li P
    Gastric Cancer; 2019 Jul; 22(4):759-768. PubMed ID: 30612230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which staging system better predicts 10-year survival for gastric cancer? A study using an international multicenter database.
    Lin JX; Lin JP; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Zheng CH; Huang CM
    Eur J Surg Oncol; 2018 Aug; 44(8):1205-1211. PubMed ID: 29804693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
    Lu J; Dai Y; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
    BMC Cancer; 2019 Mar; 19(1):216. PubMed ID: 30857518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the new seventh AJCC/UICC staging system appropriate for patients with gastric cancer?
    Yoon HM; Ryu KW; Nam BH; Cho SJ; Park SR; Lee JY; Lee JH; Kook MC; Choi IJ; Kim YW
    J Am Coll Surg; 2012 Jan; 214(1):88-96. PubMed ID: 22036661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.
    Liu K; Feng F; Chen XZ; Zhou XY; Zhang JY; Chen XL; Zhang WH; Yang K; Zhang B; Zhang HW; Zhou ZG; Hu JK
    Gastric Cancer; 2019 May; 22(3):506-517. PubMed ID: 30390154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Total Lymph Node Count on Staging and Survival After Gastrectomy for Gastric Cancer: An Analysis From a Two-Institution Database in China.
    Lu J; Wang W; Zheng CH; Fang C; Li P; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Huang CM; Zhou ZW
    Ann Surg Oncol; 2017 Feb; 24(2):486-493. PubMed ID: 27619942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proposal and validation of a modified staging system to improve the prognosis predictive performance of the 8th AJCC/UICC pTNM staging system for gastric adenocarcinoma: a multicenter study with external validation.
    Fang C; Wang W; Deng JY; Sun Z; Seeruttun SR; Wang ZN; Xu HM; Liang H; Zhou ZW
    Cancer Commun (Lond); 2018 Nov; 38(1):67. PubMed ID: 30454049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter Validation Study of the American Joint Commission on Cancer (8th Edition) for Gastric Cancer: Proposal for a Simplified and Improved TNM Staging System.
    Lin JX; Desiderio J; Lin JP; Wang W; Tu RH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Zhou ZW; Parisi A; Huang CM
    J Cancer; 2020; 11(12):3483-3491. PubMed ID: 32284744
    [No Abstract]   [Full Text] [Related]  

  • 10. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.
    Seeruttun SR; Xu L; Wang F; Yi X; Fang C; Liu Z; Wang W; Zhou Z
    Cancer Commun (Lond); 2019 Jun; 39(1):32. PubMed ID: 31182160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].
    Shi GD; Luo ZL; Fu MY; Tian D; Zhang L; Zhang KP
    Zhonghua Zhong Liu Za Zhi; 2014 Dec; 36(12):916-21. PubMed ID: 25623766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the "N" parameter-related survival: the monoinstitutional NodUs Italian study.
    Marano L; Boccardi V; Braccio B; Esposito G; Grassia M; Petrillo M; Pezzella M; Porfidia R; Reda G; Romano A; Schettino M; Cosenza A; Izzo G; Di Martino N
    World J Surg Oncol; 2015 Jul; 13():215. PubMed ID: 26179492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival comparison in gastric cancer patients between 7th and 8th edition of the AJCC TNM staging system: The first western single center experience.
    Graziosi L; Marino E; Donini A
    Eur J Surg Oncol; 2019 Jun; 45(6):1105-1108. PubMed ID: 30595468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of remnant primary, residual, and recurrent gastric cancer and applicability of the 8th AJCC TNM classification for remnant gastric cancer staging.
    Oh SE; An JY; Choi MG; Lee JH; Sohn TS; Bae JM
    Eur J Surg Oncol; 2020 Dec; 46(12):2236-2242. PubMed ID: 32788098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA.
    Chen Y; Zhang G; Zhao B; Huang C; Ling Y; Li Y; Zhou Z
    Surg Oncol; 2019 Jun; 29():90-96. PubMed ID: 31196500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database.
    Son T; Sun J; Choi S; Cho M; Kwon IG; Kim HI; Cheong JH; Choi SH; Noh SH; Woo Y; Fong Y; Park S; Hyung WJ
    J Surg Oncol; 2019 Sep; 120(4):676-684. PubMed ID: 31338834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
    Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry.
    Brenkman HJF; Cho M; Ruurda JP; Song K; Son T; Kim HI; Noh SH; van Hillegersberg R; Hyung WJ
    Eur J Surg Oncol; 2019 Jun; 45(6):983-988. PubMed ID: 30654921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of five competing lymph node staging schemes in a cohort of resectable gastric cancer patients.
    Smith DD; Nelson RA; Schwarz RE
    Ann Surg Oncol; 2014 Mar; 21(3):875-82. PubMed ID: 24242677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Western Validation of a Novel Gastric Cancer Prognosis Prediction Model in US Gastric Cancer Patients.
    Woo Y; Goldner B; Son T; Song K; Noh SH; Fong Y; Hyung WJ
    J Am Coll Surg; 2018 Mar; 226(3):252-258. PubMed ID: 29277711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.